Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum.

Tumor and normal tissues from 55 patients with papillary serous carcinoma of the peritoneum (PSCP) were analyzed. Polymerase chain reaction amplification of tandem repeat polymorphism was used to screen for loss of heterozygosity (LOH). We mapped 22 oligonucleotide primers to chromosomes 1p, 3p, 6q, 7q, 9p, 11p, 17p, 17q, and Xq. Germline BRCA1 mutation status of 43 patients was determined previously. High frequencies (> 30%) of LOH in PSCP were observed on 6q, 9p, 17p, 17q, and Xq. Compared with allelic loss of serous epithelial ovarian carcinoma (SEOC), the frequency of LOH was significantly lower in PSCP on 1p, 7q, 11p, 17p, and 17q. Of 43 cases screened for germline BRCA1 mutations, 9 cases were identified with mutations. The frequencies of LOH were not significantly different among the BRCA1-related and BRCA1-unrelated PSCP cases. The high LOH rate identified on 6q, 9p, 17p, 17q, and Xq in PSCP suggests that candidate tumor suppressor genes residing in these regions may be important for the development of the tumor. Compared with allelic loss of SEOC, PSCP exhibits a significantly lower frequency of LOH on chromosomes 1p36, 7q31.3, 11p15.1, 17p13.1, and 17q21. An increase in susceptibility to the acquisition of allelic loss in BRCA1-related PSCP cannot be identified.

[1]  R. Berkowitz,et al.  BRCA1 Gene Mutations in Women With Papillary Serous Carcinoma of the Peritoneum , 1998, Obstetrics and gynecology.

[2]  R. Berkowitz,et al.  Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. , 1998, Journal of the National Cancer Institute.

[3]  A. Godwin,et al.  Genetics and ovarian carcinoma. , 1998, Seminars in oncology.

[4]  M. Piver,et al.  Epidemiologic Differences Between Women With Extraovarian Primary Peritoneal Carcinoma and Women With Epithelial Ovarian Cancer , 1998, Obstetrics and gynecology.

[5]  R. Berkowitz,et al.  A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas , 1998, Oncogene.

[6]  M. Edelson,et al.  A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors , 1998, Oncogene.

[7]  S. Scherer,et al.  Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas , 1997, Oncogene.

[8]  Bert Vogelstein,et al.  Gatekeepers and caretakers , 1997, Nature.

[9]  S. Finkelstein,et al.  A case‐matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma , 1997, Cancer.

[10]  J Isola,et al.  Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. , 1997, Cancer research.

[11]  R. Berkowitz,et al.  A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas. , 1997, Cancer research.

[12]  Y. Nakamura,et al.  Definition of a commonly deleted region in ovarian cancers to a 300-kb segment of chromosome 6q27. , 1996, Cancer research.

[13]  S. Mok,et al.  Frequent microsatellite instability in epithelial borderline ovarian tumors. , 1996, Cancer research.

[14]  R. Berkowitz,et al.  Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. , 1996, Oncogene.

[15]  A. Godwin,et al.  Identification of two candidate tumor suppressor genes on chromosome 17p13.3. , 1996, Cancer research.

[16]  R. Berkowitz,et al.  A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. , 1996, Oncogene.

[17]  D. Pinkel,et al.  Genetic analysis of benign, low-grade, and high-grade ovarian tumors. , 1995, Cancer research.

[18]  R. Berkowitz,et al.  Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. , 1995, Oncogene.

[19]  G. Möbius,et al.  Varieties of Serous Surface Papillary Carcinoma of the Peritoneum in Northern Germany: A Thirty‐Year Autopsy Study , 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[20]  R. Berkowitz,et al.  Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. , 1995, Cancer research.

[21]  M. Killackey,et al.  Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma. , 1993, Gynecologic oncology.

[22]  A. Levine,et al.  Gain of function mutations in p53 , 1993, Nature Genetics.

[23]  R. Weinberg,et al.  Tumor suppressor genes. , 1991, Science.

[24]  M. Friedlander,et al.  Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases , 1989, Cancer.

[25]  K. Greenawald,et al.  Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases. , 1989, Human pathology.

[26]  R. Weinberg.  Oncogenes and tumor suppressor genes , 1994, CA: a cancer journal for clinicians.

[27]  J. Tobacman,et al.  INTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES , 1982, The Lancet.

[28]  A MERINO PEINADO,et al.  Recurrent Dislocation of the Shoulder , 1953, Medicina y cirugia de guerra.

[29]  L. Truong,et al.  Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases. , 1990, Human pathology.